Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 55

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 55
---
purchase an aggregate of 878,264 shares of common stock to those purchasers, whose purchase of shares of common stock in this offering
would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the
election of the purchaser, 9.99%) of our outstanding common stock following the consummation of this offering in lieu of the shares of
our common stock that would result in ownership in excess of 4.99% (or, at the election of the purchaser, 9.99%). Each Pre-Funded Warrant
will be exercisable for one share of common stock. Each Pre-Funded Warrant is being issued together with the same Warrants described above
being issued with each share of common stock. The shares of common stock or Pre-Funded Warrants, as the case may be, and the accompanying
Warrants, can only be purchased together in this offering, but the shares of common stock and Pre-Funded Warrants and accompanying Warrants
are immediately separable and will be issued separately in this offering. We are also registering the shares of common stock issuable
from time to time upon exercise of the Pre-Funded Warrants and Warrants offered hereby.

Common Stock

The description of our
common stock under “Common Stock” in this section is incorporated herein by reference.

Warrants

The following summary
of certain terms and provisions of the Warrants accompanying the shares of common stock and the Pre-Funded Warrants that are being issued
hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the Warrants, the form of which is filed
as an exhibit to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms
and provisions of the form of Warrant for a complete description of the terms and conditions of the Warrants. The Series A-1 Warrant and
Series A-2 Warrant are identical except with regard to their duration.

Duration and Exercise Price

Each Warrant offered
hereby will have an exercise price of $1.90 per share, and will be exercisable upon issuance (the “Initial Exercise Date”).
The exercise price and number of shares of common stock issuable upon exercise of the warrants is subject to appropriate adjustment in
the event of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price. The Warrants
will be